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A typical patient of mine will have a better outcome if his
or her liver transplant is performed at a higher volume
program. That fact has been known for a number of
years, and it seems to make sense to most people. After
all, practice makes perfect, right? Unfortunately, it is not
so simple in the real world. Not all patients are typical,
very few donor organs are truly average in quality, and
the performance of all transplant programs with a
certain volume of activity is not uniform.
Donor quality, an elusive concept, is partially quan-
tified by the donor risk index (DRI) for livers recovered
from deceased donors.1 The DRI is a composite mea-
sure that considers the following: the donor’s age,
race/ethnicity, and height; the cause and type of
death (eg, donation after cardiac death); the type of
graft (whole versus partial); the donor’s location with
respect to the local organ procurement organization
service area; and the cold ischemia time. On average,
for the typical patient, and at the typical liver trans-
plant program, a higher DRI is associated with worse
outcomes, and a lower DRI is associated with better
outcomes.
Lately, we have been experiencing a form of Lake
Wobegon syndrome: all donated organs seem to be
worse than average. Of course, this is not mathemati-
cally possible. However, the reverse is true: the aver-
age organ is getting worse, at least according to DRI
measurements. This is not surprising because donor
age is a prominent DRI component, and the donor
population is aging along with the rest of us.
How well are we doing with these higher DRI
organs, and are higher volume programs particularly
good at getting better results with them? In this issue
of Liver Transplantation, Ozhathil et al.2 examine
these questions and offer their take on the answers.
They analyzed data from a cohort of US deceased do-
nor liver transplants (2002-2008). They split the
cohort according to the calculated DRIs: half had a
DRI greater than 1.90, and the other half had a DRI
less than or equal to 1.90. The heart of the analysis
was focused on the half-cohort of 15,668 so-called
high-DRI transplants, which perhaps would have
been better termed higher DRI transplants.
There were not large differences between the high-,
medium-, and low-volume programs. The average
unadjusted probabilities of a functioning liver trans-
plant after 5 years were 60.3% at low-volume pro-
grams, 60.6% at medium-volume programs, and
62.6% at high-volume programs. The corresponding
probabilities of being alive were 64.7%, 66.8%, and
68.3%. In all likelihood, the ranges of these results
overlapped across the 3 program volume tertiles,
although these data are not reported. Moreover, it is
likely that some individual low- or medium-volume
programs achieved better results than certain high-
volume programs did, as previously reported by Axel-
rod et al.3 Programs should not be judged purely on
the basis of their volume.
Multivariate statistical models were used to adjust
for differences in patient and program characteristics
that might have affected the outcomes of interest and
to gauge relative outcomes. This is the ‘‘compared to
what’’ question. A higher DRI within the higher DRI
half-cohort was associated with significantly higher
risks of graft failure and patient death in comparison
with a lower DRI (again within the higher DRI half-
cohort). A higher annual center volume was also
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associated with significantly higher risks of graft fail-
ure and death. Unfortunately, some of the factors in
the final models were not significant, and the good-
ness of fit was not reported. Although this limits our
ability to interpret the results, we can still accept that
higher volume programs on average achieve better
results than lower volume programs, even when the
focus is on the 50% of donor organs that are in the
upper half of the DRI distribution.
The key question, however, is whether higher vol-
ume programs do an especially good job with truly
high-DRI organs in comparison with medium- and
low-volume programs. This critically important issue
is not addressed by Ozhathil et al.2 There are methods
that could have been applied; they could have started
with a statistical test of the interaction between the
program volume and the DRI. In other words, are the
effects of the program volume and the DRI more than
simply additive and independent? An affirmative an-
swer would have suggested that higher volume pro-
grams have identifiable attributes or practice patterns
that (1) mitigate the adverse effects of higher DRI
organs and (2) distinguish them from lower volume
programs in ways unrelated to their volume.
The authors further posit that greater experience
with higher DRI organs in higher volume programs
might lead to improved outcomes by a mass effect.2
This kind of learning curve is well established for liv-
ing donor liver transplantation4 and could be involved
here. A learning curve effect could be evaluated by the
assignment of a high-DRI case experience number to
each patient. The first patient receiving a donor liver
with a DRI > 1.90 at a given program would be
labeled high-DRI case 1, the second patient would be
labeled high-DRI case 2, and subsequent patients
would be labeled in the same fashion. The high-DRI
case number would then be tested as a covariate in
the predictive model. A significant result would sup-
port the hypothesis that increasing experience with
high-DRI livers is associated with better outcomes in-
dependently of the overall program volume.
Yet another approach would test whether all the
patients at a given program benefit if the program has
a higher median DRI. With an instrumental variable
approach,5 each program’s median DRI would be
assigned to each of the program’s patients in the anal-
ysis. If the median DRI of a program is a useful
instrument, it should be significant in the model and
trump each patient’s individual DRI.
In an era of inexorably rising DRIs, we have a press-
ing responsibility to look for ways to improve the
results of liver transplantation. Rather than just
examining an ever-longer list of patient and donor
characteristics, we must start to look at the health
care delivery system surrounding the patient. The Dial-
ysis Outcomes and Practice Patterns Study is a good
example of this approach.6 Dialysis facilities are scru-
pulously surveyed to identify practices that may por-
tend better or worse outcomes. When significant asso-
ciations between facility practices and outcomes are
identified, this kind of study serves a useful hypothe-
sis-generating function and permits the formulation of
quantitatively developed markers of best practices.
In liver transplantation, we know a lot about the
patients and their donors. It is now time for us to
deconstruct the center effect and focus on our pro-
grams and our practices as determinants of outcomes
after liver transplantation.
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